AstraZeneca Pharma India informs about board meeting

14 Jan 2016 Evaluate

AstraZeneca Pharma India has informed that a meeting of the Board of Directors of the Company will be held on February 06, 2016, to consider and approve the Unaudited Financial Results of the Company for the quarter ended December 31, 2015. Further the Trading Window shall remain closed for all Designated Persons, from December 16, 2015 to February 08, 2016 in terms of AstraZeneca Pharma India - Code of Conduct for Prevention of Insider Trading framed under Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015.

The above information is a part of company’s filings submitted to BSE.

Astrazeneca Pharma I Share Price

8908.70 -254.05 (-2.77%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×